Immunization of children after solid organ transplantation

Pediatric Clinics of North America

Volumn 50, Issue 6, 2003, Pages 1435-1449

  Lopez, M James ^a   Thomas, Susan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CALCINEURIN INHIBITOR; CHICKENPOX VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INTERLEUKIN 2; INTERLEUKIN 5; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; SMALLPOX VACCINE; TYPHOID VACCINE; VACCINE; YELLOW FEVER VACCINE;

BACTERIAL MENINGITIS; BCG VACCINATION; BRAIN DISEASE; CHICKENPOX; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG SAFETY; GRAFT FAILURE; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; MEASLES; MEASLES VACCINATION; MUMPS; MYELITIS; MYOCARDITIS; ORGAN TRANSPLANTATION; PERICARDITIS; PERTUSSIS; POLIOMYELITIS; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; REVIEW; REYE SYNDROME; RISK BENEFIT ANALYSIS; RUBELLA; SIDE EFFECT; STREPTOCOCCUS INFECTION; TUBERCULOSIS;

EID: 0345734343     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(03)00125-1     Document Type: Review

References (87)

1. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000;30(6):857-69.
2. Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998;11(1):1-26.
3. Stark K, Gunther M, Schonfeld C, Tullius SG, Bienzle U. Immunizations in solid-organ transplant recipients. Lancet 2002;359(9310):957-65.
4. Neuberger J. Immunosuppressive drugs. In: Maddrey WC, Sorrell MF, editors. Transplantation of the liver. 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 199-209.
5. nd edition. Mt. Laurel (NJ): American Society of Transplantation; 2001. p. 87-98.
6. American Academy of Pediatrics. 2000 red book: report of the Committee on Infectious Diseases. 25th edition. Elk Grove (IL): American Academy of Pediatrics; 2000.
7. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992;267(9):1237-41.
8. Arakawa Y, Matsui A, Sasaki N, Nakayama T. Agranulocytosis and thrombocytopenic purpura following measles infection in a living-related orthotopic liver transplantation recipient. Acta Paediatr Jpn 1997;39(2):226-9.
9. Bakshi N, Lawson J, Hanson R, Ames C, Vinters HV. Fatal mumps meningoencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation. J Child Neurol 1996;11(2):159-62.
10. Mazariegos GV, Green M, Reyes J, Nour B, Tzakis A, Starzl TE. Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994;13(2):161-2.
11. CDC. Measles, mumps, and rubella: vaccine use and strategies for the elimination of measles, rubella, and congenital rubella syndrome and control of mumps. MMWR Recomm Rep 1998;47(RR 8):1-57.
12. McLaughlin M, Thomas P, Onorato I, et al. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective study. Pediatrics 1988;82:229-33.
13. Monafo WJ, Haslam DB, Roberts RL, Zaki SR, Bellini WJ, Coffin CM. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 1994;124(2):273-6.
14. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1994;43(RR-1):1-38.
15. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989;159(4):610-5.
16. Torigoe S, Hirai S, Oitani K, et al. Application of live attenuated measles and mumps vaccines in children with acute leukemia. Biken J 1981;24(4):147-51.
17. Furth SL, Neu AM, Sullivan EK, Gensler G, Tejani A, Fivush BA. Immunization practices in children with renal disease: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997;11(4):443-6.
18. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993;123(1):87-9.
19. King SM, Saunders EF, Petric M, Gold R. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 1996;17(4):633-6.
20. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994;84(2):657-63.
21. Dunn DT, Newell ML, Peckham CS, Vanden Eijden S. Routine vaccination and vaccine-preventable infections in children born to human immunodeficiency virus-infected mothers: European collaboratives. Acta Paediatr 1998;87(4):458-9.
22. CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1-18.
23. Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA. Varicella in the first year after renal transplantation: a report of the North American pediatric renal transplant cooperative study (NAPRTCS). Pediatr Transplant 1997;1(1):37-42.
24. CDC. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45(RR-11):1-36.
25. CDC. Prevention of varicella: update recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 1999;48(RR-6):1-5.
26. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106(2 Pt 1):362-6.
27. Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994;8(2):190-2.
28. Gershon AA, Steinberg S. Persistence of immunity to varicella in children with leukemia immunized with a live attenuated varicella virus. N Engl J Med 1989;320:892-7.
29. CDC. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR Recomm Rep 1996;45(RR 4):1-18.
30. CDC. Poliomyelitis prevention in the United States. MMWR Recomm Rep 2000;49(RR 5): 1-22.
31. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. Pediatrics 1999;103(1):171-2.
32. Balloni A, Assael BM, Ghio L, et al. Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation. Vaccine 1999;17(20-21):2507-11.
33. CDC. Prevention and control of influenza. MMWR Recomm Rep 2002;51(RR 3):1-31.
34. Hayden FG. Prevention and treatment of influenza in immunocompromised patients. Am J Med 1997;102(3A):55-60 [discussion: 75].
35. Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transplant 2000;6(5):531-42.
36. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med 2000;160(1):113-5.
37. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999;67(5):753-5.
38. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993;31(11):553-6.
39. Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996;10(6 Pt 1):556-60.
40. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996;22(2):295-302.
41. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998;17(11):1075-80.
42. Dengler TJ, Stmad N, Buhring I, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998;66(10):1340-7.
43. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000;61(1):85-93.
44. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998;13(1):160-4.
45. Doebbeling BN, Feilmeier ML, Herwaldt LA. Pertussis in an adult man infected with the human immunodeficiency virus. J Infect Dis 1990;161(6):1296-8.
46. de Martino M, Podda A, Galli L, et al. Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection. Vaccine 1997;15(11):1235-8.
47. Enke BU, Bokenkamp A, Offner G, Bartmann P, Brodehl J. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 1997;64(2):237-41.
48. Pedrazzi C, Ghio L, Balloni A, et al. Duration of immunity to diphtheria and tetanus in young kidney transplant patients. Pediatr Transplant 1999;3(2):109-14.
49. Vance E, George S, Guinan EC, et al. Comparison of multiple immunization schedules for Haemophilus influenzae type B-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998;22(8):735-41.
50. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4 + lymphocytes. AIDS 1994;8(4):469-76.
51. Ghio L, Pedrazzi C, Assael BM, Panuccio A, Foti M, Edefonti A. Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant. J Pediatr 1997;130(6):987-9.
52. Amber IJ, Gilbert EM, Schiffman G, Jacobson JA. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 1990;49(1):122-5.
53. Dengler TJ, Strnad N, Zimmermann R, et al. Pneumococcal vaccination after heart and liver transplantation: immune responses in immunosuppressed patients and in healthy controls. Dtsch Med Wochenschr 1996;121(49):1519-25.
54. Linnemann Jr CC, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 1981;141(12):1637-40.
55. Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986;154(4):590-6.
56. McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000;181(2):757-60.
57. Kazancioglu R, Sever MS, Yuksel-Onel D, et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 2000;14(1):61-5.
58. CDC. Preventing pneumococcal disease among infants. MMWR Recomm Rep 2000;49(RR 9): 1-38.
59. Mermel LA, Maki DG. Bacterial pneumonia in solid organ transplantation. Semin Respir Infect 1990;5(1):10-29.
60. Robbins JB, Schneerson R, Anderson P, Smith DH. The 1996 Albert Lasker medical research awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type B: impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996;276(14):1181-5.
61. Sever MS, Yildiz A, Eraksoy H, et al. Immune response to Haemophilus influenzae type B vaccination in renal transplant recipients with well-functioning allografts. Nephron 1999;81(1): 55-9.
62. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 1999;48(RR 12): 1-37.
63. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998;27(3):881-6.
64. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J 1993;12:359-62.
65. Neilsen GA, Bodsworth NJ, Watts N. Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men. J Infect Dis 1997;176(4): 1064-7.
66. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the immunization practices advisory committee. MMWR Recomm Rep 1991;40(RR 13):1-19.
67. Dodson S, Issa S, Bonham A. Liver transplantation for chronic viral hepatitis. Surg Clin North Am 1999;79:131-45.
68. Fabia R, Levy MF, Crippin J, et al. De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transplant Surg 1998;4(2):119-27.
69. Loinaz C, de Juanes JR, Gonzalez EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44(13):235-8.
70. Kallinowski B, Benz C, Buchholz L, Stremmel W. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc 1998;30(3):797-9.
71. Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990;85(12): 1590-2.
72. Van Thiel DH, el-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992;37(8):1245-9.
73. Horlander JC, Boyle N, Manam R, et al. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci 1999;318(5):304-7.
74. Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transplant Surg 1998;4(2):128-32.
75. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Invest 1992;70(7):585-7.
76. Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 1993;11(4):397-9.
77. Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987;316:673-6.
78. CDC. Vaccinia (smallpox) vaccine: recommendations of the advisory committee on immunization practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR 10):1-25.
79. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970;122:303-9.
80. Lane JM, Millar JD, Neff JM. Smallpox and smallpox vaccination policy. Annu Rev Med 1971;22:251-72.
81. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med 1969;281:1201-8.
82. CDC. Human rabies prevention: United States, 1999. MMWR Recomm Rep 1999;48(RR 1): 1-21.
83. CDC. Yellow fever vaccine recommendations of the advisory committee on immunization practices (ACIP), 2002. MMWR Recomm Rep 2002;51(RR 17):1-10.
84. CDC. Inactivated Japanese encephalitis virus vaccine. MMWR Recomm Rep 1993;42(RR 1): 1-15.
85. Poland JD, Cropp CB, Craven RB, Monath TP. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990;161:878-82.
86. Yamada A, Imanishi J, Juang RF. Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases. Vaccine 1986;4:32-4.
87. CDC. Typhoid immunization. MMWR Recomm Rep 1994;43(RR 14):1-7.